The Discounted Cash Flow (DCF) valuation of Urogen Pharma Ltd (URGN) is (155.35) USD. With the latest stock price at 11.44 USD, the upside of Urogen Pharma Ltd based on DCF is -1458.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 10.0% | 8.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (358.15) - (102.00) | (155.35) |
| Upside | -3230.7% - -991.6% | -1458.0% |